CNC
Centene Corporation
HOSPITAL & MEDICAL SERVICE PLANS
Centene (CNC) Stock: Buy, Sell, or Hold?
$71.27
+1.00 (+1.42%)
â˛
5d:
+2.19%
30d:
+1.08%
90d:
+10.65%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Oct 27, 2026
0d
Protect CNC Gains
Updated Nov 13, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (61%)
Quality Score
47/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$66.23 â $71.52
Position: SLIGHTLY HIGH
Forward P/E & Valuation
12.9x
FAIR
vs 12.5x historical avg
Wall Street Target
$75.39
+5.8% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$64.85 / $78.08
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: CNC is fairly priced but lacks strong directional signals. At 0.8% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Smart Money Distribution
Options positioning is turning defensive after a sharp run-up - a pattern consistent with institutional profit-taking. View Scanner →
Signal fired Nov 4, 2026 at $72.27 · last confirmed Nov 12, 2026
Strength: 8.7/10
Get Alerted When CNC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$86.38
Based on 4.5% avg growth
INTRINSIC VALUE TODAY
$53.63
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CNC is currently trading at $71.27, which is considered slightly high relative to its 30-day fair value range of $66.23 to $71.52. The stock's valuation (Forward PE: 12.8) is in line with its historical norms (12.5). At these levels, the market is pricing in 0.8% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, CNC is in a strong downtrend. Immediate support is located at $64.85, while resistance sits at $78.08.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CNC is in a strong downtrend. Immediate support is located at $64.85, while resistance sits at $78.08.
Market Sentiment: The stock scores a mixed 44/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$66.23 -
$71.52
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.4%
Trading Range & Key Levels
30-Day Trading Range
$66.23 -
$71.52
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$64.85
Resistance Level
$78.08
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Protect Your Profits
Holding CNC? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- NEUTRAL: Mixed technical signals (44/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($75.39)
- NEUTRAL: Market pricing in 0.8% annual earnings growth - fairly valued
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
12.85
Wall Street Target
$75.39
(+5.8%)
Revenue Growth (YoY)
0.2%
Earnings Growth (YoY)
18.3%
Profit Margin
0.8%
Valuation Premium vs History
+0.8% premium
PE vs Historical
12.9 vs 12.5
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.8%
(market-implied from PE analysis)
1-Year Target
$71.84
(+1%)
2-Year Target
$72.41
(+2%)
3-Year Target
$72.99
(+2%)
3-Yr Target (if PE normalizes)
(PE: 13â13)
PE COMPRESSION
$70.99
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 5.0%)
$127.31
(+79%)
Base:
(SPY PE: 12.9, Growth: 5.0%)
$82.39
(+16%)
Bear:
(PE: 10.9, Growth: 5.0%)
$70.03
(-2%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 24.22 | Current EPS (TTM): $2.91
Bull Case
$147.73
(+110%)
Analyst growth 90.6%, PE expands to 26.6
Base Case
$134.30
(+91%)
Market implied 90.6%, PE stable at 24.2
Bear Case
$47.93
(-32%)
Severe decline -20.0%, PE contracts to 20.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share CNC Analysis
Share this live CNC analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CNC)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 27, 2026
Daily AI digest
AI Retail Discussion Summary:
Centene Corporation reported Q3 earnings surpassing estimates, with a profit recovery in the Medicare and Marketplace segments. The company expects the Medicare Advantage business to reach financial breakeven in 2026.
Key Retail Themes:
earnings beat
profit recovery
Medicare Advantage progress
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:56 PM ET
Data refreshes hourly during market hours. Next update: 6:56 PM
Data refreshes hourly during market hours. Next update: 6:56 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNC showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
27 analysts |
$115 | 60 HOLD |
|
UNH
UnitedHealth Group IncorâĻ |
STRONG BUY
26 analysts |
$477 | 55 HOLD |
|
CI
The Cigna Group |
STRONG BUY
24 analysts |
$342 | 46 HOLD |
|
ELV
Elevance Health Inc |
BUY
22 analysts |
$482 | 49 HOLD |
|
HUM
Humana Inc |
BUY
26 analysts |
$465 | 34 SELL |
Advanced CNC Option Strategies
Professional options setups generated by AI based on today's CNC price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CNC Research Pages
